Daniel West

Daniel West is an accomplished professional in the pharmaceutical industry with extensive experience in business development and licensing. Currently serving as Vice President of Business Development & Licensing at ADVANZ PHARMA since December 2018, Daniel West plays a key role in delivering value through a diverse portfolio of specialty generic and off-patent medicines. Prior to this, Daniel held the same title at Concordia International since October 2018 and was Managing Director at Dexcel Pharma from October 2016 to September 2018. Daniel West has also held various leadership positions in renowned companies such as Chanelle, Niche Generics Ltd, Goldshield Pharmaceuticals Limited, and IVAX Pharmaceuticals, demonstrating a strong track record in product commercialization and international business development.